CareDx, Inc
NASDAQ:CDNA
28.87 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 280.324 | 321.793 | 296.397 | 192.194 | 127.068 | 76.569 | 48.324 | 40.631 | 28.144 | 27.306 | 22.098 | 20.451 |
| Cost of Revenue
| 104.456 | 112.212 | 97.389 | 63.117 | 45.455 | 32.987 | 21.371 | 21.122 | 10.273 | 8.541 | 9.078 | 7.93 |
| Gross Profit
| 175.868 | 209.581 | 199.008 | 129.077 | 81.613 | 43.582 | 26.953 | 19.509 | 17.871 | 18.765 | 13.02 | 12.521 |
| Gross Profit Ratio
| 0.627 | 0.651 | 0.671 | 0.672 | 0.642 | 0.569 | 0.558 | 0.48 | 0.635 | 0.687 | 0.589 | 0.612 |
| Reseach & Development Expenses
| 81.866 | 90.388 | 76.525 | 48.941 | 30.711 | 14.514 | 12.388 | 12.385 | 9.333 | 3.846 | 3.176 | 4.752 |
| General & Administrative Expenses
| 117.868 | 100.397 | 74.964 | 48.806 | 36.54 | 21.959 | 18.913 | 20.725 | 12.247 | 8.436 | 4.809 | 4.694 |
| Selling & Marketing Expenses
| 83.334 | 96.027 | 77.245 | 53.858 | 38.894 | 21.67 | 12.808 | 11.166 | 8.349 | 6.472 | 5.892 | 5.417 |
| SG&A
| 195.902 | 196.424 | 152.209 | 102.664 | 75.434 | 43.629 | 31.721 | 31.891 | 20.596 | 14.908 | 10.701 | 10.111 |
| Other Expenses
| 1.343 | -2.872 | -2.628 | -4.813 | -0.719 | -0.178 | -1.49 | -1.92 | -0.188 | 0.147 | -0.536 | -0.014 |
| Operating Expenses
| 277.768 | 286.812 | 228.734 | 146.792 | 106.145 | 58.143 | 44.109 | 44.276 | 29.929 | 18.754 | 13.877 | 14.863 |
| Operating Income
| -101.9 | -77.231 | -29.726 | -17.715 | -24.532 | -15.578 | -20.294 | -37.332 | -11.932 | 1.25 | -0.857 | -2.342 |
| Operating Income Ratio
| -0.364 | -0.24 | -0.1 | -0.092 | -0.193 | -0.203 | -0.42 | -0.919 | -0.424 | 0.046 | -0.039 | -0.115 |
| Total Other Income Expenses Net
| -88.243 | 0.997 | -2.362 | -2.035 | 0.585 | -29.953 | -34.25 | -14.735 | -0.062 | 1.386 | -0.536 | -0.014 |
| Income Before Tax
| -190.143 | -76.234 | -32.088 | -19.75 | -23.947 | -48.215 | -57.269 | -41.362 | -13.707 | -0.719 | -3.542 | -5.059 |
| Income Before Tax Ratio
| -0.678 | -0.237 | -0.108 | -0.103 | -0.188 | -0.63 | -1.185 | -1.018 | -0.487 | -0.026 | -0.16 | -0.247 |
| Income Tax Expense
| 0.141 | 0.379 | -1.426 | -1.036 | -1.979 | -1.434 | -1.709 | -1.606 | 0.665 | -1.5 | 2.149 | 2.703 |
| Net Income
| -190.284 | -76.613 | -30.662 | -18.714 | -21.968 | -46.756 | -55.469 | -39.469 | -13.707 | 0.781 | -3.542 | -5.059 |
| Net Income Ratio
| -0.679 | -0.238 | -0.103 | -0.097 | -0.173 | -0.611 | -1.148 | -0.971 | -0.487 | 0.029 | -0.16 | -0.247 |
| EPS
| -3.54 | -1.44 | -0.59 | -0.4 | -0.52 | -1.31 | -2.38 | -2.39 | -1.16 | 0.13 | -0.48 | -0.69 |
| EPS Diluted
| -3.54 | -1.44 | -0.59 | -0.4 | -0.52 | -1.31 | -2.38 | -2.39 | -1.16 | 0.1 | -0.48 | -0.69 |
| EBITDA
| -82.076 | -77.338 | -29.832 | -16.22 | -24.851 | -14.739 | -18.646 | -26.687 | -12.184 | -1.228 | -0.194 | -1.27 |
| EBITDA Ratio
| -0.293 | -0.24 | -0.101 | -0.084 | -0.196 | -0.192 | -0.386 | -0.657 | -0.433 | -0.045 | -0.009 | -0.062 |